Abstract
Selective decontamination of the digestive tract (SDD) is probably the most investigated clinical intervention in critically ill patients treated in intensive care units (ICU). Several meta-analysis studies have been published underlining its efficacy and significance in the reduction of infections in the critically ill patient, especially of ventilator-associated pneumonia (VAP) and bloodstream infections with consequent reductions of mortality by 20% [1]–[3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D’Amico R, Pifferi S, Leonetti C et al (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 316:1275–1285
Nathens AB, Marshall JC (1999) Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 134: 170–176
Heyland DK, Cook DJ, Jaeschke R et al (1994) Selective decontamination of the digestive tract. An overview. Chest 105:1221–1229
Stoutenbeek CP, van Saene HKF, Miranda DR et al (1987) The effect of oropharyngeal decontamination using topical non-absorbable antibiotics on the incidence of nosocomial respiratory infections in multiple trauma patients. J Trauma 27:357–364
Baxby D, van Saene HKF, Stoutenbeek CP et al (1996) Selective decontamination of the digestive tract: 13 years on, what it is and what it is not. Intensive Care Med 22:699–706
Fridkin SK, Gaynes RP (1999) Antimicrobial resistance in intensive care units. Clin Chest Med 20:303–316
Toltzis Ph, Yamashita T, Vilt L et al (1997) Colonization with antibiotic Gram-negative organisms in a paediatric intensive care unit. Crit Care Med 25:538–544
Garrouste-Orgeas M, Marie O, Rouveau M et al (1996) Secondary carriage with multiresistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality. J Hosp Infect 34: 279–289
Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 281:1137–1140
Van Saene HKF, Stoutenbeek CP, Geitz JN et al (1988) Effect of amoxycillin on ‘colonisation resistance’ in human volunteers. Microb Ecol Health Dis 1:169–177
Mobbs KJ, van Saene HKF, Sunderland D et al (1999) Oropharyngeal Gram-negative bacillary carriage. Chest 115:1570–1575
Mackowiak PA, Martin RM, Jones SR et al (1978) Pharyngeal colonisation by Gram-negative bacilli in aspiration prone persons. Arch Intern Med 138:1224–1227
Fuxench-Lopez Z, Ramirez-Ronda CH (1978) Pharyngeal flora in ambulatory alcoholic patients. Arch Intern Med 138:1815–1816
Mobbs KJ, van Saene HKF, Sunderland D et al (1999) Oropharyngeal Gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease. Respir Med 93:540–545
Morris JG, Shay DK, Hebden JN et al (1995) Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 123:250–259
Coque TM, Tomayko JF, Ricke SC et al (1996) Vancomycin-resistant enterococci from nosocomial, community and animal sources in the United States. Antimicrob Agents Chemother 40:2605–2609
Pujol M, Pena C, Pallares R et al (1996) Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 100:509–516
Sanchez-Garcia M, Cambronero-Galache JA, Lopez-Diaz J et al (1998) Effectiveness and costs of selective decontamination of the digestive tract in critically ill intubated patients. Am J Respir Crit Care Med 158:908–916
van der Voort PH, van der Hulst RW, Zandstra DF et al (2001) Suppression of Helicobacter pylori infection during intensive care stay: related to stress ulcer bleeding incidence? J Crit Care 16:182–187
Daschner FD, Frey P, Wolff G et al (1982) Nosocomial infections in intensive care wards: a multicenter prospective study. Intensive Care Med 8:5–9
Rangel-Frausto MS, Pittet D, Costigan M et al (1995) The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 273:117–123
Source: Algemeen Nederlands Persbureau.
Fagon JY, Chastre J, Wolff M et al (2000) Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 132:621–630
Canadian Critical Care Trials Group; Heyland D, Dodek P, Muscedere J et al (2006) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355:2619–2630
de Man P, Verhoeven BA, Verbrugh HA et al (2000) An antibiotic policy to prevent emergence of resistant bacilli: Lancet 355:973–978
Wolff M (1998) Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. The Cefpirome Pneumonia treatment group Antimicrob Agents Chemother 42:28–36
Brun-Buisson C, Sollet JP, Schweich H et al (1998) Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group. Clin Infect Dis 26:346–354
Beaucaire G, Nicolas MH, Martin C (1999) Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study. Ann Fr Anesth Reanim 18:186–195
Klein BS, Perloff WH, Maki DG (1989) Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 320:1714–1721
van der Waaij D, van der Waaij JM (1985) Spread of multiresistant gram-negative bacilli among severely immuno-compromised mice during prophylactic treatment with different oral antimicrobial drugs. Prog Clin Biol Res 181:245–250
Baines PB, Taylor N, Sarginson RE et al. (2006) Emergence of antimicrobial resistance in a paediatric intensive care unit (PICU). Pediatr Crit Care Med Suppl 3rd World Congress, book of Abstracts, 165 FP16 Infectious Diseases.
de la Cal MA, Cerda E, Calderon M et al. Oral vancomycin in the control of MRSA outbreaks in ICU. In: van Saene HKF, Sganga G, Silvestri L (eds) Infection in the critically ill: an ongoing challenge. Springer-Verlag Italia, Milan 2001, pp 139–146
Hammond JMJ, Potgieter PD (1995) Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med 23:637–645
Stoutenbeek CP, van Saene HKF, Zandstra DF (1987) The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 19:513–520
Lingnau W, Berger J, Javorsky F et al (1998) Changing bacterial ecology during a five-year period of selective intestinal decontamination. J Hosp Infect 39:195–206
van der Voort PHJ, van Roon EN, Kampinga GA et al (2004) A before-after study of multi-resistance and cost of selective decontamination of the digestive tract. Infection 32:271–277
Viviani M, van Saene HK, Dezzoni R et al (2005) Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose-response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care 33:361–372
Sarginson RE, Taylor N, Reilly N et al (2004) Infection in prolonged pediatric critical illness: a prospective four-year study based on knowledge of the carrier state. Crit Care Med 32:839–842
Heininger A, Meyer E, Schwab F et al (2006) Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance. Intensive Care Med 32:1569–1576
Leone M, Albanese J, Antonini F et al (2003) Long-term (6 year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Crit Care Med 31:2090–2095
De la Cal MA, Cerda E, van Saene HK et al (2004) Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 56:175–183
Cerda E, Abella A, de la Cal MA et al (2007) Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit. A 9-year prospective study. Ann Surg 245:397–407
Tetteroo GWM, Wagenvoort JHT, Bruining HA (1994) Bacteriology of selective decontamination: efficacy and rebound colonization. J Antimicrob Chemother 34:529–544
Saunders N, Hammond JMJ, Potgieter PD et al (1994) Microbiological surveillance during selective decontamination of the digestive tract (SDD). J Antimicrob Chemother 34:529–544
Silvestri L, van Saene HK (2006) Selective decontamination of the digestive tract does not increase resistance in critically ill patients: evidence from randomized controlled trials. Crit Care Med 34:2027–2029
de Jonge E, Schultz MJ, Spanjaard L et al (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362(9389):1011–1016
Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of nosocomial multi-resistant-gram-negative bacilli. Ann Intern Med 110:873–881
Damjanovic V, van Saene HK (2005) Microbial mutation as a source of polyclonality in the gut of the critically ill. J Hosp Infect 59:374–375
Taylor ME, Oppenheim BA (1991) Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 71:271–278
Agusti C, Pujol M, Argerich MJ et al (2002) Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother 49:205–208
Al Naiemi N, Heddema ER, Bart A et al (2006) Emergence of multidrug-resistant Gramnegative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother 58:853–856
Gastinne H, Wolff M, Delatour F et al (1992) A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. N Engl J Med 326:594–599
Hammond JM, Potgieter PD, Saunders GL et al (1992) Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 340:5–9
Ferrer M, Torres A, Gonzalez J et al (1994) Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 120:389–395
Wiener J, Itokazu G, Nathan C et al (1995) A randomized, double-blind, placebo controlled trial of selective digestive decontamination in a medical, surgical intensive care unit. Clin Infect Dis 20:861–867
Lingnau W, Berger J, Javorsky F et al (1997) Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 42:687–694
Verwaest C, Verhaegen J, Ferdinande P et al (1997) Randomized controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multi-disciplinary intensive care unit. Crit Care Med 25:63–71
De la Cal MA, Cerda E, Garcia-Hierro P et al (2005) Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebocontrolled, double-blind trial. Ann Surg 241:424–430
Silvestri L, van Saene HK, Milanese M et al (2004) Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 23:921–926
Geraci JE, Heilman FR, Nichols DR et al (1956) Some laboratory and clinical experiences with a new antibiotic, vancomycin. Mayo Clin Proc 31:564–582
Currie BP, Lemos-Filho L (2004) Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci. Antimicrob Agents Chemother 48:4427–4429
Tedesco F, Markham R, Gurwith M et al (1978) Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet II/8083:226–228
Arnow PM, Carandang GC, Zabner R et al (1996) Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 22:997–1003
Hellinger WC, Yao JD, Alvarez S et al (2002) A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 73:1904–1909
Bergmans DC, Bonten MJ, Gaillard CA et al (2001) Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 164:382–388
Gaussorgues P, Salord F, Sirodot M et al (1991) Efficacité de la décontamination digestive sur la survenue des bactériémies nosocomiales chez les patients sous ventilation méchanique et recevant des betamimétiques. Réanimation Soins Intensifs Médecin d’Urgence 7:169–174
Korinek AM, Laisne MJ, Nicolas MH et al (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebocontrolled study. Crit Care Med 21:1466–1473
Krueger WA, Lenhart FP, Neeser G et al (2002) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 166:1029–1037
Pugin J, Auckenthaler R, Lew DP et al (1991) Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, doubleblind clinical trial. JAMA 265:2704–2710
Schardey HM, Joosten U, Finke U et al (1997) The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 225:172–180
Sanchez M, Mir N, Canton R, Luque R et al (1997) The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphylococcus aureus in critically ill patients. A double-blind, randomised, placebo-controlled study. 37th ICAAC, 1997, Toronto, Canada, Abstract J-119, p. 310
Stiefel U, Paterson DL, Pultz NJ et al (2004) Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers. Infect Control Hosp Epidemiol 25:380–383
Salgado CD, Gianetta ET, Farr BM (2004) Failure to develop vancomycin-resistant enterococci in San Francisco Bay area hospitals during 1994 to 1998. Infect Control Hosp Epidemiol 25:413–417
Hendrix CW, Hammond JMJ, Swoboda SM et al (2001) Surveillance strategies and impact of vancomycin-resistant enterococcal colonisation and infection in critically ill patients. Ann Surg 233:259–265
Slaughter S, Hayden MK, Nathan C et al (1996) A comparison of the effect of universal use of gloves and gowns with that of glove alone on acquisition of vancomycin resistant enterococci in a medical intensive care unit. Ann Intern Med 125:448–456
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Zandstra, D.F., van Saene, H.K.F., van der Voort, P.H.J. (2008). Antimicrobial Resistance During 20 Years of Clinical SDD Research. In: van der Voort, P.H.J., van Saene, H.K.F. (eds) Selective Digestive Tract Decontamination in Intensive Care Medicine: a Practical Guide to Controlling Infection. Springer, Milano. https://doi.org/10.1007/978-88-470-0653-9_9
Download citation
DOI: https://doi.org/10.1007/978-88-470-0653-9_9
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0652-2
Online ISBN: 978-88-470-0653-9
eBook Packages: MedicineMedicine (R0)